Metal(II) complexes of bioactive aminonaphthoquinone-based ligand: synthesis,characterization and BSA binding,DNA binding/cleavage,and cytotoxicity studies

An aminonaphthoquinone ligand, L, and its metal complexes of general formula [MLCl₂] {M = Co(II), Ni(II), Cu(II) and Zn(II)} have been synthesized and characterized by analytical and spectral techniques. Tetrahedral geometry has been assigned to Ni(II) and Zn(II) complexes and square planar geometry to Co(II) and Cu(II) complexes on the basis of electronic spectral and magnetic susceptibility data. The binding of complexes with bovine serum albumin (BSA) is relatively stronger than that of free ligand and alters the conformation of the protein molecule. Interaction of these complexes with CT-DNA has been investigated using UV-Vis and fluorescence quenching experiments, which show that the complexes bind strongly to DNA through intercalative mode of binding (K_app 10⁵ M^?1). Molecular docking studies reiterate the mode of binding of these compounds with DNA, proposed by spectral studies. The ligand and its complexes cleave plasmid DNA pUC18 to nicked (Form II) and linear (Form III) forms in the presence of H₂O₂ oxidant. The in vitro cytotoxicity screening shows that Cu(II) complex is more potent against MCF-7 cells and Zn(II) complex exhibits marked cytotoxicity against A-549 cells equal to that of cisplatin. Cell imaging studies suggested apoptosis mode of cell death in these two chosen cell lines.     

Tricarbonylrhenium(I) complexes with the N,6-dimethylpyridine-2-carbothioamide ligand: combined experimental and calculation studies

Abstract

A new series of tricarbonyl complexes of rhenium(I) in the “2 + 1” system with the bidentate ligand N,6-dimethylpyridine-2-carbothioamide ((CH₃)NC₅H₄-CS-NH-CH₃, MeLH(Me)_NS) and a monodentate ligand (halides Cl, Br, or I, and the pseudohalide NCS anion) was synthesized. The use of mixed ligands led to the formation of neutral tricarbonylrhenium(I) complexes [Re(CO)₃(MeLH(Me)_NS)X] (X = Cl, Br, I, NCS) (1–4). Single-crystal X-ray diffraction was used to determine the crystal structures of all four compounds and those results were compared with molecular structures obtained from DFT calculations using the PBE0/def2-TZVPD approach. The complexes were also characterized by spectroscopic (FT-IR, NMR, and UV–vis) and analytical (HPLC, TGA, EA, ESI-MS) techniques. IR and UV–vis spectra were also calculated by DFT and TD-DFT methods. The cytotoxicity of these complexes was estimated using human ovarian cancer cell lines (A2780 and A2780cis), cervical cancer cells (HeLa), and non-cancerous human embryonic kidney cells (Hek-293). The toxicity of most complexes was moderate or low toward cancer cell lines (IC₅₀ = 46–231 μM) and similar against non-cancerous cells (IC₅₀ = 41-121 μM). Only the complex with chlorido ligand remarkably inhibited growth of ovarian cancer cells (IC₅₀ = 3 and 12 μM for A2780 and A2780cis, respectively). The cytotoxicity of 1 was higher than that of cisplatin.     

Theoretical,antimicrobial, antioxidant,in vitro cytotoxicity,and cyclin-dependent kinase 2 inhibitor studies of metal(II) complexes with bis(imidazol-1-yl)methane-based heteroscorpionate ligands

Abstract

A series of C-centered heteroscorpionate-based homoleptic manganese(II), nickel(II), and copper(II) complexes of type [M(L^1–3)₂] (1–9) have been synthesized by using the ligands (2-hydroxyphenyl)bis(imidazol-1-yl)methane (HL¹), (4-diethylamino-2-hydroxyphenyl)bis(imidazol-1-yl)methane (HL²) and (5-bromo-2-hydroxyphenyl)bis(imidazol-1-yl)methane (HL³). The geometric parameters of the complexes were determined using UV-vis and theoretical studies suggesting distorted octahedral geometry around metal(II) ion. Frontier molecular orbital analysis supports bioefficacy of the complexes. Antimicrobial activity of the metal(II) complexes were determined against two Gram(–ve) (Escherichia coli and Klebsiella pneumoniae) and two Gram(+ve) (Bacillus cereus and Staphylococcus aureus) bacteria, and three fungal (Candida albicans, Candida glabrata, and Candida krusei) strains. Antioxidant activity of nickel(II) and copper(II) complexes were evaluated against ABTS, DPPH, and H₂O₂ free radicals. In vitro cytotoxicity activity of nickel(II) and copper(II) complexes against human breast adenocarcinoma (MCF-7), cervical (HeLa), and lung (A549) cancer cell lines along with one normal human dermal fibroblasts (NHDF) cell line were carried out by MTT assay, which shows the potent activity of copper(II) complex 8 with respect to the standard drug cisplatin. Molecular docking studies evidence the interaction of complexes with cyclin-dependent kinase 2 receptor (CDK2).     

Synthesis,characterization and in vitro DNA binding studies of a new copper(II) complex containing an antiviral drug,valganciclovir

A new complex, [Cu(valcyte)₂(NO₃)₂], in which valcyte served as a valganciclovir drug, was synthesized and characterized by different physicochemical methods. Optimization of ligand structures and their complexes with Cu²⁺ were performed by semi-empirical and DFT methods. Binding interaction of this complex with calf-thymus DNA (ct-DNA) was explored by emission, absorption, circular dichroism and viscosity techniques. Additionally, cell line targeting was studied and cytotoxic effects of [Cu(valcyte)₂(NO₃)₂] (0.0–160 μg) on AGS and MCF-7 cell lines were reported. Percentage of Cell Viability and Apoptotic Index were assessed. The complex displayed significant binding properties to ct-DNA. Undertaking fluorometric studies, the binding mode of the complex with ct-DNA was explored utilizing Hoechst as a fluorescence probe, indicating the binding to be of groove mode. The DNA viscosity altered slightly in presence of the complex. Enthalpy and entropy changes during the interaction showed that the process is endothermic, with the complex mainly bound to ct-DNA by hydrophobic attraction. Values of ΔG revealed a spontaneous reaction between DNA and the complex. Optimized docked model of DNA–complex mixture confirmed the experimental results. The results of MMFF94 calculations indicated stability of [Cu(valcyte)₂(NO₃)₂] after docking with the modeled DNA profile, as compared to the DNA profile and valganciclovir results before the docking process. Cytotoxicity studies showed that an increase in [Cu(valcyte)₂(NO₃)₂] may result in a significant decrease in cell viability and increase apoptosis index in the treated cells, as compared to valganciclovir treated cells (p < 0.05). The findings further showed that [Cu(valcyte)₂(NO₃)₂] has potential for use in cancer therapy.     

Synthesis and biological evaluation of water-soluble trans-[bicyclo[2.2.2]octane-7R,8R-diamine]platinum(II) complexes with linear or branched alkoxyacetates as leaving groups

Four platinum(II) complexes, trans-[bicyclo[2.2.2]octane-7R,8R-diamine]bis(alkoxyacetato-O,O’) platinum(II) (alkoxyacetate = methoxyacetate (2), ethoxyacetate (3), isopropoxyacetate (4), and tert-butoxyacetate (5)) were synthesized and spectrally characterized. The cytotoxicity of these water-soluble complexes was evaluated by CCK-8 assay in vitro against HCT-116, HepG-2, and A549 cancer cell lines. Most of the complexes had cytotoxic activity against the tested cancer cell lines. Among them, 3 showed more potent antitumor effect than cisplatin or oxaliplatin. Complex 3 could cause HCT-116 cell line death based on an apoptotic pathway since it has a dicyclic moiety similar to 1R,2R-diaminocyclohexane in oxaliplatin. Agarose gel electrophoresis on the interaction between 3 and DNA indicated that it has different behavior from that of cisplatin or oxaliplatin, which has a high correlation with the ligand used.     

Heteroleptic Pd(II) dithiocarbamates: synthesis,characterization, packing and in vitro anticancer activity against HeLa cell line

Two new heteroleptic Pd(II) dithiocarbamates (1 and 2) have been synthesized by reaction of equimolar quantities of palladium(II) chloride, sodium 4-(3-methoxyphenyl)piperazine-1-carbodithioate, and appropriate substituted triphenylphosphines. The synthesized complexes have been characterized by their physical, spectral (IR, ¹H, ¹³C, and ³¹P NMR), and X-ray crystallographic data. Complexes 1 and 2 showed square-planar geometry both in solution and solid states. The crystal packing of both complexes revealed similar 3-D-supramolecular networks comprised of 1-D chains. However, the nature and strength of various non-covalent interactions of these networks were slightly different. The DNA interaction studies of the complexes have been carried out by UV–visible spectroscopy to evaluate their anticancer potential. The study suggested intercalative interaction with 2.402 × 10⁴ and 2.713 × 10³ M^?1 binding constants, respectively. The complexes have also been evaluated for their anticancer activity against HeLa cell line. Both complexes showed higher activity with IC₅₀ values much lower (22.176 and 26.166 μM for 1 and 2, respectively) than the standard cisplatin (78.075 μM). Furthermore, the complexes induced stronger DNA fragmentation as investigated by DNA ladder assay for apoptosis. Our findings suggested that the anticancer action of these compounds stems from their interaction with DNA leading to DNA damage and apoptosis. The excellent activity of 1 and 2 deserves to be a focus for further research and in vivo studies.     

Mixed ligand Cu(II) complexes containing o-vanillin-l-tryptophan Schiff base and heterocyclic nitrogen bases: synthesis,structural characterization,and biological properties

[Cu(L)] (1) and mixed ligand copper(II) complexes [Cu(L)(A)] (2 and 3), where L is the Schiff base derived from o-vanillin and l-tryptophan and A is pyridine (2) and imidazole (3), were synthesized and characterized using conventional and spectral techniques. 2 was structurally characterized using single crystal X-ray crystallography showing that Cu(II) is coordinated through N₂O₂ donors in a square plane. The EPR spectra of the complexes in frozen solution support a square-based structure. Electrochemical behavior of the complexes has been studied by cyclic voltammetry. The DNA-binding properties of L and 1–3 with calf thymus DNA were investigated by spectral and kinetic methods. For all the complexes, the maximum value of binding constant (0.38 × 10⁶) was achieved with 3 by spectroscopic titration. The ability of compounds to break pUC19 DNA was checked by gel electrophoresis. The ligand and copper complexes exert cytotoxicity against MCF-7 cell line.     

Synthesis,cytotoxicity, and interaction with DNA of platinum(II) complexes of (1R,2R)-N1-2-amyl-1,2-diaminocyclohexane

(1R,2R)-N¹-2-amyl-1,2-diaminocyclohexane, which has an amyl substituent as compared with 1,2-diaminocyclohexane, was used as the carrier group to construct three platinum(II) complexes. MTT assay revealed that the complexes showed decent cytotoxicity against all of the four tested tumor cell lines with the IC₅₀ values ranging from 1.08 to 253.36 μM. Particularly, the IC₅₀ values of 2 against A549 and HCT-116 reached 3.32 and 1.08 μM, respectively, which were much lower than those of cisplatin and oxaliplatin. Flow cytometry demonstrated that 2 inhibited HepG2 cells proliferation and caused cytotoxicity by inducing apoptosis and arresting cells in the G2 phase. Furthermore, agarose gel electrophoresis showed that 2 had the ability to interact with DNA in a manner different from cisplatin and oxaliplatin, indicating the carrier ligand with an alkyl moiety had an influence on the action mode of the complex.     

Synthesis,characterization and luminescent properties of three-coordinate copper(I) halide complexes containing diphenylamino monodentate phosphine ligand

Three-coordinate copper halide complexes with a bidentate phosphine ligand have received much attention. Here, a series of three-coordinate dinuclear copper halide complexes containing a diphenylamino monodentate phosphine ligand, [CuX(dpnp)]₂ (dpnp = N-[2-(diphenylphosphino)-4,5-dimethylphenyl]-N-phenylaniline, X = I (1), Br (2) and Cl (3)), were synthesized, and their molecular structures and photophysical properties were investigated. The structural analysis reveals that two copper(I) centers are bridged by two halogen ligands to form a dinuclear structure with a four-membered Cu₂X₂ ring. Crystal structures of 1–3 contain 1-D supramolecular arrays constructed by intermolecular C–H?π interactions. These complexes exhibit blue emission in the solid state at room temperature and have peak emission wavelengths at 483–487 nm with microsecond lifetimes (τ = 13.9–38.1 μs) and low emission quantum yields (<0.01%). The emission of complex 1 mainly originates from intraligand (IL) transition, whereas the emissions of complexes 2 and 3 are from a combination of MLCT, XLCT and IL transitions. The three complexes displayed good thermal stability.     

Synthesis,characterization, and crystal structures of cobalt(II), copper(II), and zinc(II) complexes of a bidentate iminophenol

A bidentate iminophenol (HL = 2-((4-methoxyphenylimino)methyl)-4,6-di-tert-butylphenol derived from condensation of 4-methoxyaniline and 3,5-di-tert-butyl-2-hydroxybenzaldehyde) was mixed with divalent metal salts to form the corresponding mononuclear metal complexes [M^II(L)₂] (M = Co (1), Cu (2), and Zn (3)). The complexes are characterized by different spectroscopic and analytical tools. X-ray crystal structures of the complexes revealed homoleptic mononuclear complexes with MN₂O₂ coordination. The cobalt(II) (1) and zinc(II) (3) complexes display a pseudo-tetrahedral coordination geometry, whereas the copper(II) complex (2) exhibits a distorted square-planar coordination. The zinc(II) complex (3) emits at 460 nm with a twofold enhancement of emission with respect to the free iminophenol.     

Ruthenium(II) complexes of pyrrol-azo ligands: cytotoxicity,interaction with calf thymus DNA and bovine serum albumin

Two ruthenium(II) complexes of newly designed pyrrol-azo ligands(L) and bipyridine(bpy) formulated as [Ru(L)(bpy)₂]ClO₄, where HL^1?=?(4-chloro-phenyl)-(1H-pyrrol-2-yl)-diazene (1) complex 1 and HL^2?=?(4-nitro-phenyl)-(1H-pyrrol-2-yl)-diazene for 2, were isolated in pure form. The complexes were characterized by physicochemical and spectroscopic methods. The electrochemical behavior of the complexes showed the Ru(III)/Ru(II) couple at different potentials with quasi-reversible voltammograms. The study of cytotoxicity effects of 1 and 2 on human breast cancer cells (MCF 7, MDA-MB 231) and cervical cancer cell (HeLa) taking Cisplatin as a positive reference showed that 1 exhibited higher cytotoxicity against cancer cell lines than 2, but less activity than Cisplatin. The interaction of 1 with calf thymus DNA (CT-DNA) using absorption, emission spectral studies, viscosity-measurement, and electrochemical techniques has been used to determine the binding constant K _b and the linear Stern–Volmer quenching constant K _SV. The results indicate that 1 strongly interacts with CT-DNA in groove binding mode. The interaction of bovine serum albumin (BSA) with 1 was also investigated with the help of spectroscopic tools. Absorption spectroscopy proved the formation of a BSA-[Ru(L¹)(bpy)₂]ClO₄ complex.     

Cobalt(II) complexes with thiosemicarbazone as potential antitumor agents: synthesis,crystal structures,DNA interactions,and cytotoxicity

Two cobalt(II) complexes [Co(QCT)₂]·Cl·1.5H₂O (1) (QCT = quinoline-2-carboxaldehyde thiosemicarbazone) and [Co(QCMT)(CH₃OH)Cl₂] (2) (QCMT = quinoline-2-carboxaldehyde N⁴-methyl-thiosemicarbazone) have been synthesized and structurally characterized. Complex 1 crystallizes in a triclinic system with space group P–1 and complex 2 crystallizes in a monoclinic system with space group P2(1)/n. In both complexes the cobalt(II) center is six coordinated with distorted octahedral geometry. The interactions of two complexes with CT-DNA were investigated by electronic absorption spectra, circular dichroism (CD) spectra and fluorescence spectra. Results suggest that the complexes bind to DNA via groove binding mode, and complex 2 has stronger binding ability than complex 1. The in vitro cytotoxicity has been tested against the human lung adenocarcinoma cell line A-549, cisplatin-resistant cell line A-549/CDDP, and human breast adenocarcinoma cell line MCF-7. Complex 2 is more cytotoxic than complex 1, and both of them show higher cytotoxicity than the parent ligands alone. Compared with cisplatin, the two cobalt(II) complexes are more active against A-549/CDDP and MCF-7 cell lines at most experimental concentrations. Notably, although complex 2 is found to be less effective than cisplatin against the parent cell line A-549, it is much more effective than cisplatin against the resistant cell A-549/CDDP.     

Two MnII,CuII complexes derived from 3,5‐bis(1‐imidazoly) pyridine: Synthesis,DNA binding,Molecular docking and cytotoxicity studies

Two complexes [MnL₂ (H₂O)₂]·2ClO₄ (complex 1) and [CuL(H₂O)₃]·2NO₃ (complex 2) (where L = 3,5‐bis(1‐imidazoly) pyridine) were designed and synthesized. The structures of the complexes were characterized by X‐ray crystallography, elemental analyses, and infrared spectrum. The interaction capacity of the complexes with calf thymus DNA has been investigated by UV and fluorescence spectroscopy. Gel electrophoresis assay demonstrated the ability of the complexes to cleave the pBR322 plasmid DNA. Efficient binding properties of DNA were established by UV–vis, fluorescence, and gel electrophoresis. The intrinsic binding constants (K_b) were calculated to be 0.1524, 0.1041 for complexes 1–2, respectively. The cytotoxic activity of the two complexes exhibited a higher cytotoxicity against HeLa cell lines and lower cytotoxicity toward the normal cell lines. Flow cytometry demonstrated the cancer cell inhibitory rate of two complexes. Furthermore, computer‐aided molecular docking studies were performed to visualize the binding mode of the drug candidate at the molecular level. Interestingly, complex 1 exhibited a significant cancer cell inhibitory rate than cisplatin and other complexes.     

菲咯啉与1-萘甲酸配体共同构筑的多核Ca(Ⅱ)、双核Mn(Ⅱ)配合物的合成、结构及性质

设计、合成了2种配合物：[Ca(Phen)(Nap)₂]_n(1)和[Mn₂(Phen)₂(Nap)₄(H₂O)](2)(Phen=菲咯啉,HNap=1-萘甲酸)。通过红外光谱、元素分析、X射线单晶衍射和热重对其进行了结构表征。测定了配合物的激发光谱、发射光谱,以及配合物对人肺癌细胞(NCI-H460)、人乳腺癌细胞(MCF-7)、人肝癌细胞(HepG2)的体外抑制活性;利用紫外吸收光谱、荧光分光光度法研究了配合物与小牛胸腺DNA的相互作用。结果表明：配合物1、2的激发光谱和发射光谱具有很好的镜像关系,且配合物2的斯托克斯位移大于配合物1;配合物对3种癌细胞都有较好的抑制作用,但是2更优于1;配合物1和2与小牛胸腺DNA以静电作用发生沟面结合,结合常数分别为5.83×10³和6.46×10³L·mol^-1。     

Synthesis,characterization and antimicrobial activity of a bidentate NS Schiff base of S-benzyl dithiocarbazate and its divalent complexes

The reaction of S-benzyl dithiocarbazate (SBDTC) with 2,4,5-trimethoxybenzaldehyde afforded a bidentate NS Schiff base 1 (benzyl-3-N-(2,4,5-trimethoxyphenylmethylenehydrazine carbodithioate), which on further reaction with M(II) (where M(II) = nickel(II), zinc(II), palladium(II) and copper(II)) in ethanol under reflux yielded bis-chelated inner complexes [ML₂] 2–5 with deprotonated L. The ligand and its complexes were characterized by physicochemical techniques, viz., molar conductance, magnetic susceptibility measurement, IR, NMR, UV–Vis and mass spectroscopic techniques. The crystal structures of 1 and 5 were also determined by single-crystal X-ray crystallography. The crystal structure analysis showed that the ligand exists in its thione tautomeric form. In the complexes, each of the two deprotonated ligands chelated the metal ions through the β-nitrogen and the thione sulfur forming five-membered rings. The copper(II) complex (5) exhibited a square-planar geometry, where the two N₂S₂ chromophores are arranged trans. All the compounds showed strong antibacterial activity against S.-β-hemolyticus, Klebsiella pneumoni, and Escherichia coli. The compounds also showed strong antifungal activity against Aspergillus fumigatus, Aspergillus niger, Aspergillus flavus, and Candida albicans with the exception of the palladium(II) complex (4) which showed no activity, while all the compounds showed no activity against Fusarium vasinfectum.     

Dinuclear phenoxo-bridged “end-off” complexes containing a piperazine that shows chemical nuclease and cytotoxic activities

Three dinuclear cobalt(II), nickel(II), and copper(II) complexes (1–3) of a phenol-based ‘end-off’ compartmental ligand, 2,6-bis[1-(N-ethyl)piperazineiminomethyl]-4-methylphenol (HL), have been synthesized and characterized by spectral analysis. The molecular structure of one of these complexes, 2,6-bis[1-(N-ethyl)piperazineiminomethyl]-4-methylphenolato-diaqua-μ-hydroxo-μ-nitrato-dicobalt(II) nitrate, [Co₂(H₂L)(μ-OH)(μ-NO₃)(H₂O)₂](NO₃)₃] (1), was determined by single crystal X-ray crystallography. The complex exhibits a distorted octahedral geometry around cobalt with a Co–Co distance of 2.9882(8)?Å. Electrochemical studies of 1–3 reveal that the redox processes are due to ligand reactions. The EPR spectrum of 3 showed a broad signal at g?=?2.11 indicating magnetic interaction between the two copper ions. The μ_eff values for 1 and 3 are 4.94 and 1.93 BM, respectively, which indicate a spin–spin interaction between the metal ions. Complex 3 caused a cleavage of circular plasmid pBR322 DNA into nicked circular and linear forms in the presence of a co-reactant. Human epidermoid carcinoma cells, A431, were employed for in vitro cytotoxicity studies of the synthesized complexes. The IC₅₀ value of 3 is lower than that of the other two complexes. The copper complex (3) exhibited better chemical nuclease and cytotoxic activity than the other two complexes.     

Design,synthesis and theoretical analysis of functionalized dicarboxylate moieties based on organotin(IV) dinuclear complexes: crystal structure elucidation and biological studies

Dinuclear tin(IV) dicarboxylate complexes of the types [(n-Bu)₂Sn(oda)(4-pic)]₂·2H₂O (1) and [(n-Bu)₂Sn(pda)(H₂O)]₂ (2) [H₂oda = oxydiacetic acid; H₂pda = pyridine 2,6-dicarboxylic acid) were synthesized and characterized via physicochemical and spectroscopic studies. The spectroscopic results indicated that Sn is seven-coordinate having pentagonal bipyramidal (pbp) geometry in both complexes. The X-ray study of complex 2 further specified pentagonal bipyramidal geometry with dinuclear structural arrangement due to the involvement of carboxylate bridges formed by pda^2? moiety. The crystal structure is further stabilized by different weak interactions viz., C–C?H, C–C?O, C–H?O, C–C?O, and C–H?H. These interactions are further supported by Hirshfeld surface analysis along with 2-D fingerprint plots of complex 2. In vitro DNA-binding studies of both complexes were evaluated using spectroscopic techniques (absorbance and fluorescence) which ascertained optimum binding affinity of both complexes. However, cleavage activity of the complexes was assessed using supercoiled DNA (pBR322) via gel electrophoresis technique which demonstrated significant cleavage pattern of both complexes at different concentrations. Furthermore, chemotherapeutic potential of complexes 1 and 2 against MCF-7 and Hep carcinoma cell lines also suggested significant antiproliferative effect of complexes. These results revealed momentous exploration of drug–DNA interactions which may engender new insinuation for the advancement of metallo-pharmaceuticals.     

Synthesis,characterization and luminescent properties of three-coordinate copper(I) halide complexes containing 2-(diphenylphosphino)biphenyl

Highly emissive three-coordinate copper halide complexes with a bidentate phosphine ligand have attracted attention. Here, a series of three-coordinate mono- and dinuclear copper halide complexes, [CuI(dpbp)₂] (1) and [CuX(dpbp)]₂ (dpbp = 2-(diphenylphosphino)biphenyl, X = Br (2), Cl (3)), were synthesized, and their molecular structures and photophysical properties were investigated. In the solid state, these complexes exhibit green photoluminescence with microsecond lifetimes (λ_max = 515–538 nm; τ = 11.8–19.1 μs) at 298 K. The emission of the complexes originates from the (σ + X) → π* transition. All three complexes displayed good thermal stability.     

Oxidative DNA cleavage by Cu(II) complexes of 1,10-phenanthroline-5,6-dione

A dimeric dichloro-bridged copper(II) complex [Cu₂(pdon)₂Cl₄] · 2DMF (1) and two mononuclear copper(II) complexes [Cu(pdon)(DMSO)Cl₂] · DMSO · H₂O (2) and [Cu(pdon)₃] · (ClO₄)₂ · 2.25CH₃CN · 6H₂O (3) (pdon = 1,10-phenanthroline-5,6-dione) have been synthesized and characterized. Variable-temperature magnetic susceptibility studies indicate the existence of weak anti-ferromagnetic coupling in the binuclear complex. The interaction of these complexes with CT-DNA (calf thymus DNA) has been studied using absorption and emission spectral methods. The apparent binding constants (K _app) for 1, 2 and 3 are 5.20 × 10⁵, 2.68 × 10⁵ and 7.05 × 10⁵ M^?1, respectively, showing moderate intercalative binding modes. All of these complexes cleave plasmid DNA to nicked DNA in a sequential manner as the concentration or reaction time is increased. The cleavage mechanism between the complex and plasmid DNA is likely to involve singlet oxygen ¹O₂ and ?OH as reactive oxygen species.     

Synthesis,characterization and medical efficacy (hepatoprotective and antioxidative) of albendazole-based copper(II) complexes – an experimental and theoretical approach

A series of albendazole-based copper(II) complexes with different counter anions, [Cu(Albz)(H₂O)₂](ClO₄)₂ (1), [Cu(Albz)₂(Cl)]Cl·2H₂O (2), [Cu(Albz)₂(NO₃)](NO₃) (3), and [Cu₂(Albz)₂(μ-SO₄)₂(H₂O)₂] (4) (Albz = albendazole), have been synthesized and characterized. Their structures and properties were characterized by elemental analysis, thermal analysis (TGA, DTG and DTA), IR, UV–vis and ESR spectroscopies, cyclic voltammetry, electrical molar conductivity, and magnetic moment measurements. A square-planar geometry is proposed for 1, whereas the five-coordinate copper(II) complexes 2, 3, and 4 have a square pyramidal geometry. Theoretical calculations (DFT) using B3LYP/6–311 + G(d,p) level of theory corroborated the experimental results to investigate both the drug Albz and its copper(II) complex, 1. The hepatoprotective and antioxidative efficacy of Albz and 1–4 were evaluated against carbon tetrachloride-induced acute hepatotoxicity in rats. Hepatotoxicity in experimental rats was evidenced by significant decrease in the antioxidant enzyme activities (SOD, GSH-S-transfers, and GSH-Rd levels). The results have strong impact for designing anticancer drugs, combined with their potential cytotoxic and antioxidant activities, which can be targeted selectively against cancer cells and increase their therapeutic index and advantages over other anticancer drugs. The DNA cleavage studies of Albz and its copper(II) complexes using genomic DNA indicated that Albz has no role in cleavage of DNA, and only 1 played a marked role in the DNA cleavage without any external additives.